With AI automating routine workflows behind the scenes, intelligent systems let healthcare professionals devote themselves fully to face-to-face care, while listening closely and applying their expertise. The post How AI is Strengthening The Human Connection In Medicine appeared first on MedCity News.
As hospitals nationwide search to improve the cleanliness of their facilities, infection control continues to be one of their biggest challenges. The challenge of preventing healthcare associated infections persists for several reasons: pathogens have become more resistant; patient flow demands have put added pressure to quickly clean and disinfect patient rooms; and human error, partly…
Microsoft launched Copilot Health, an AI model that pulls together users’ medical records, wearable data and trusted health information. The move comes amid a wave of other tech companies announcing healthcare-focused large language models for consumers, including Anthropic, OpenAI and Amazon. The post Microsoft Enters Healthcare Chatbot Race with Copilot Health appeared first on MedCity…
As scrutiny from CMS and the FCC increases, Medicare marketers must rethink how they source, verify, and engage leads. Taking the focus off lead volume and redirecting it to lead quality will help them demonstrate they run an ethical operation. The post Lead Quality vs. Lead Volume: What Matters Most When Serving Vulnerable Populations appeared first…
OpenAI announced a new dedicated platform for health conversations. The company said the new offering is not intended for medical diagnosis or treatment — but rather to provide support for personal health navigation. The post OpenAI Launches ChatGPT Health: 5 Things to Know appeared first on MedCity News.
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes. But the topline results don’t show an advantage over Eli Lilly’s commercialized obesity medication, Zepbound. The post Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss…
La primera señal apareció cuando Deepanwita Dasgupta tenía 5 años y empezó a tropezar más a menudo mientras jugaba en su casa en Bangalore, en el sur de India. La niña siempre estaba haciendo algo; por eso sus padres pensaron que los golpes y moretones extra eran simplemente parte de una infancia activa. Quizás, pensaron,…
Cybersecurity experts predict cybersecurity attacks will continue to happen with more sophistication
Bristol Myers Squibb’s partnership with BioNTech makes it the third big pharma company to strike a deal to gain access to a PD-L1/PD-1 and VEGF bispecific antibody with potential use in drug combinations to treat cancer. The deal calls for the two companies to share in the development of BioNTech’s drug and co-commercialize the asset…